Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Inflammatory Bowel Diseases | 86 | 2024 | 2430 | 12.480 |
Why?
|
Crohn Disease | 77 | 2024 | 2281 | 9.350 |
Why?
|
Drug Monitoring | 36 | 2024 | 960 | 8.740 |
Why?
|
Gastrointestinal Agents | 38 | 2024 | 511 | 7.600 |
Why?
|
Colitis, Ulcerative | 52 | 2024 | 1912 | 5.380 |
Why?
|
Tumor Necrosis Factor-alpha | 36 | 2023 | 4342 | 4.240 |
Why?
|
Biological Products | 14 | 2024 | 947 | 2.940 |
Why?
|
Azathioprine | 8 | 2022 | 354 | 2.410 |
Why?
|
Colonoscopy | 14 | 2020 | 1408 | 2.050 |
Why?
|
Antibodies, Monoclonal | 30 | 2024 | 9239 | 1.940 |
Why?
|
Colitis | 9 | 2022 | 1239 | 1.740 |
Why?
|
Remission Induction | 19 | 2024 | 2413 | 1.690 |
Why?
|
Immunosuppressive Agents | 15 | 2022 | 4213 | 1.670 |
Why?
|
Practice Guidelines as Topic | 14 | 2021 | 7423 | 1.520 |
Why?
|
Immunologic Factors | 13 | 2024 | 1590 | 1.470 |
Why?
|
Capsule Endoscopy | 6 | 2021 | 107 | 1.250 |
Why?
|
Anti-Inflammatory Agents | 8 | 2024 | 1802 | 1.070 |
Why?
|
Mesalamine | 9 | 2016 | 133 | 1.040 |
Why?
|
Gastroenterology | 5 | 2021 | 593 | 1.020 |
Why?
|
Guideline Adherence | 5 | 2020 | 2234 | 1.000 |
Why?
|
Conflict of Interest | 6 | 2016 | 556 | 0.990 |
Why?
|
Serum | 3 | 2017 | 205 | 0.970 |
Why?
|
Evidence-Based Medicine | 7 | 2016 | 3690 | 0.950 |
Why?
|
Endoscopy, Gastrointestinal | 5 | 2023 | 889 | 0.880 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 14 | 2016 | 2270 | 0.860 |
Why?
|
Medical Records | 4 | 2017 | 1408 | 0.840 |
Why?
|
Bronchial Diseases | 2 | 2014 | 151 | 0.830 |
Why?
|
Humans | 198 | 2024 | 765926 | 0.810 |
Why?
|
Standard of Care | 4 | 2022 | 568 | 0.800 |
Why?
|
Rectal Fistula | 2 | 2024 | 76 | 0.770 |
Why?
|
Sickness Impact Profile | 2 | 2013 | 297 | 0.770 |
Why?
|
Pulmonary Medicine | 2 | 2014 | 223 | 0.770 |
Why?
|
Documentation | 3 | 2017 | 911 | 0.740 |
Why?
|
Colectomy | 3 | 2015 | 697 | 0.730 |
Why?
|
Intestinal Fistula | 1 | 2021 | 146 | 0.690 |
Why?
|
Nephrology | 2 | 2014 | 270 | 0.690 |
Why?
|
Intestinal Neoplasms | 2 | 2020 | 314 | 0.680 |
Why?
|
Calculi | 1 | 2019 | 48 | 0.640 |
Why?
|
Fertilization in Vitro | 3 | 2016 | 1301 | 0.630 |
Why?
|
Triage | 2 | 2015 | 994 | 0.600 |
Why?
|
Hepatitis B Core Antigens | 1 | 2018 | 90 | 0.590 |
Why?
|
Hepatitis B Antibodies | 1 | 2018 | 156 | 0.570 |
Why?
|
Irritable Bowel Syndrome | 2 | 2013 | 454 | 0.570 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2018 | 293 | 0.550 |
Why?
|
Adult | 75 | 2024 | 223088 | 0.530 |
Why?
|
Diarrhea | 3 | 2017 | 1315 | 0.530 |
Why?
|
Drug Tolerance | 2 | 2018 | 365 | 0.530 |
Why?
|
Coloring Agents | 1 | 2019 | 562 | 0.530 |
Why?
|
Colonic Neoplasms | 5 | 2020 | 2530 | 0.530 |
Why?
|
Hepatitis B virus | 2 | 2018 | 532 | 0.530 |
Why?
|
Light | 2 | 2020 | 1364 | 0.530 |
Why?
|
Arthritis, Psoriatic | 1 | 2019 | 218 | 0.520 |
Why?
|
Immunocompromised Host | 2 | 2012 | 865 | 0.520 |
Why?
|
Virus Activation | 1 | 2018 | 322 | 0.510 |
Why?
|
Helicobacter pylori | 1 | 2019 | 380 | 0.510 |
Why?
|
Helicobacter Infections | 1 | 2019 | 390 | 0.510 |
Why?
|
Cannabis | 1 | 2021 | 446 | 0.490 |
Why?
|
Middle Aged | 66 | 2024 | 223016 | 0.490 |
Why?
|
Disease Management | 6 | 2021 | 2530 | 0.480 |
Why?
|
Male | 88 | 2024 | 363815 | 0.480 |
Why?
|
Obstetric Labor Complications | 1 | 2017 | 239 | 0.470 |
Why?
|
C-Reactive Protein | 8 | 2024 | 3851 | 0.470 |
Why?
|
Apyrase | 5 | 2020 | 376 | 0.470 |
Why?
|
Complementary Therapies | 2 | 2016 | 486 | 0.460 |
Why?
|
Infertility | 3 | 2016 | 655 | 0.450 |
Why?
|
Female | 90 | 2024 | 396141 | 0.450 |
Why?
|
Therapeutic Irrigation | 2 | 2014 | 297 | 0.440 |
Why?
|
Herpesvirus 3, Human | 2 | 2012 | 157 | 0.430 |
Why?
|
Emergency Service, Hospital | 4 | 2018 | 7871 | 0.420 |
Why?
|
Intestine, Small | 4 | 2013 | 1216 | 0.420 |
Why?
|
Pouchitis | 3 | 2022 | 64 | 0.420 |
Why?
|
Treatment Outcome | 30 | 2024 | 65194 | 0.410 |
Why?
|
Intestinal Obstruction | 2 | 2006 | 433 | 0.400 |
Why?
|
Mycobacterium marinum | 1 | 2012 | 29 | 0.400 |
Why?
|
Barrett Esophagus | 1 | 2016 | 494 | 0.390 |
Why?
|
Coronary Angiography | 2 | 2014 | 4498 | 0.390 |
Why?
|
Antirheumatic Agents | 2 | 2012 | 1378 | 0.390 |
Why?
|
Herpes Zoster | 2 | 2012 | 252 | 0.390 |
Why?
|
Treatment Failure | 5 | 2019 | 2653 | 0.390 |
Why?
|
Skin Diseases, Bacterial | 1 | 2012 | 65 | 0.390 |
Why?
|
Chickenpox | 1 | 2012 | 95 | 0.370 |
Why?
|
Drug Evaluation | 1 | 2012 | 642 | 0.370 |
Why?
|
Mycophenolic Acid | 1 | 2013 | 348 | 0.370 |
Why?
|
Cannabinoids | 1 | 2013 | 174 | 0.370 |
Why?
|
Cryptosporidium | 1 | 2011 | 43 | 0.370 |
Why?
|
Cryptosporidiosis | 1 | 2011 | 52 | 0.370 |
Why?
|
Cyclosporine | 2 | 2011 | 777 | 0.370 |
Why?
|
Comparative Effectiveness Research | 3 | 2020 | 713 | 0.370 |
Why?
|
Th17 Cells | 5 | 2022 | 786 | 0.360 |
Why?
|
Pharmaceutical Preparations | 1 | 2019 | 1084 | 0.360 |
Why?
|
Drug Hypersensitivity | 2 | 2014 | 903 | 0.360 |
Why?
|
Capsule Endoscopes | 2 | 2009 | 13 | 0.350 |
Why?
|
Arthritis, Rheumatoid | 2 | 2019 | 3743 | 0.350 |
Why?
|
Medication Adherence | 5 | 2015 | 2190 | 0.340 |
Why?
|
Adrenal Cortex Hormones | 4 | 2014 | 1881 | 0.340 |
Why?
|
Tomography, X-Ray Computed | 5 | 2016 | 20690 | 0.340 |
Why?
|
Delivery, Obstetric | 1 | 2017 | 947 | 0.340 |
Why?
|
Infertility, Female | 1 | 2016 | 763 | 0.340 |
Why?
|
Osteoporosis | 1 | 2019 | 1582 | 0.330 |
Why?
|
Iatrogenic Disease | 1 | 2013 | 551 | 0.330 |
Why?
|
Retrospective Studies | 26 | 2024 | 81537 | 0.330 |
Why?
|
Vaccines, Attenuated | 1 | 2011 | 313 | 0.330 |
Why?
|
Opportunistic Infections | 1 | 2012 | 376 | 0.330 |
Why?
|
Cellulitis | 1 | 2011 | 206 | 0.320 |
Why?
|
Colonic Polyps | 1 | 2014 | 557 | 0.320 |
Why?
|
Immunomodulation | 1 | 2013 | 548 | 0.320 |
Why?
|
Health Priorities | 1 | 2012 | 382 | 0.310 |
Why?
|
Attitude of Health Personnel | 3 | 2021 | 3928 | 0.310 |
Why?
|
Research Support as Topic | 1 | 2012 | 697 | 0.300 |
Why?
|
Drug Substitution | 2 | 2021 | 292 | 0.300 |
Why?
|
Tumor Necrosis Factors | 2 | 2019 | 109 | 0.300 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2020 | 4055 | 0.300 |
Why?
|
Young Adult | 27 | 2024 | 59857 | 0.300 |
Why?
|
Cesarean Section | 1 | 2017 | 1418 | 0.300 |
Why?
|
Potentilla | 1 | 2007 | 1 | 0.300 |
Why?
|
Infusions, Parenteral | 1 | 2008 | 395 | 0.290 |
Why?
|
Patient Care | 1 | 2013 | 628 | 0.290 |
Why?
|
Congenital Abnormalities | 1 | 2013 | 704 | 0.290 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2020 | 10727 | 0.280 |
Why?
|
Cytomegalovirus Infections | 1 | 2013 | 837 | 0.270 |
Why?
|
Endoscopes, Gastrointestinal | 1 | 2006 | 45 | 0.270 |
Why?
|
Adenoma | 2 | 2014 | 2155 | 0.270 |
Why?
|
Colon | 5 | 2017 | 1796 | 0.260 |
Why?
|
Lichen Planus, Oral | 1 | 2007 | 56 | 0.260 |
Why?
|
Colorectal Neoplasms | 3 | 2014 | 6958 | 0.260 |
Why?
|
Hepatitis B | 1 | 2011 | 709 | 0.250 |
Why?
|
Antigens, CD | 4 | 2020 | 4023 | 0.250 |
Why?
|
Private Practice | 2 | 2017 | 154 | 0.250 |
Why?
|
Education, Medical | 1 | 2017 | 1744 | 0.250 |
Why?
|
Clinical Protocols | 3 | 2009 | 1435 | 0.250 |
Why?
|
Skin Diseases | 1 | 2014 | 1083 | 0.250 |
Why?
|
Severity of Illness Index | 12 | 2023 | 15878 | 0.240 |
Why?
|
Ambulatory Care | 2 | 2015 | 2778 | 0.240 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 3801 | 0.240 |
Why?
|
Prospective Studies | 19 | 2023 | 54807 | 0.230 |
Why?
|
Quality Indicators, Health Care | 1 | 2014 | 1804 | 0.230 |
Why?
|
Prognosis | 15 | 2023 | 29890 | 0.230 |
Why?
|
Digestive System Surgical Procedures | 1 | 2009 | 581 | 0.220 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2024 | 92 | 0.220 |
Why?
|
Plant Extracts | 1 | 2007 | 493 | 0.220 |
Why?
|
Endoscopy | 4 | 2020 | 1854 | 0.220 |
Why?
|
Infusions, Intravenous | 4 | 2014 | 2227 | 0.220 |
Why?
|
Randomized Controlled Trials as Topic | 10 | 2022 | 10380 | 0.210 |
Why?
|
Mucous Membrane | 3 | 2023 | 658 | 0.210 |
Why?
|
Colonic Pouches | 3 | 2016 | 122 | 0.210 |
Why?
|
Biological Therapy | 1 | 2024 | 140 | 0.210 |
Why?
|
Hypersensitivity, Immediate | 1 | 2005 | 346 | 0.200 |
Why?
|
Autoimmune Diseases | 1 | 2014 | 2248 | 0.200 |
Why?
|
Delphi Technique | 3 | 2021 | 893 | 0.190 |
Why?
|
Ileitis | 1 | 2022 | 40 | 0.190 |
Why?
|
Antibodies | 3 | 2023 | 2415 | 0.190 |
Why?
|
Physicians | 2 | 2017 | 4591 | 0.190 |
Why?
|
Cohort Studies | 12 | 2020 | 41680 | 0.190 |
Why?
|
Odds Ratio | 5 | 2020 | 9656 | 0.190 |
Why?
|
Time Factors | 10 | 2024 | 40097 | 0.190 |
Why?
|
Consensus | 4 | 2021 | 3202 | 0.190 |
Why?
|
Patient Readmission | 1 | 2015 | 3282 | 0.180 |
Why?
|
Hospitalization | 4 | 2018 | 10810 | 0.180 |
Why?
|
Predictive Value of Tests | 6 | 2018 | 15401 | 0.180 |
Why?
|
Wound Healing | 4 | 2024 | 2794 | 0.180 |
Why?
|
Pregnancy Complications | 2 | 2013 | 2970 | 0.180 |
Why?
|
Adolescent | 14 | 2023 | 88811 | 0.180 |
Why?
|
Probiotics | 3 | 2016 | 387 | 0.180 |
Why?
|
Venous Thromboembolism | 1 | 2014 | 1883 | 0.180 |
Why?
|
Research Design | 2 | 2015 | 6204 | 0.180 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2022 | 705 | 0.170 |
Why?
|
RNA, Antisense | 1 | 2020 | 135 | 0.170 |
Why?
|
Societies, Medical | 5 | 2021 | 3953 | 0.170 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2020 | 355 | 0.170 |
Why?
|
Early Detection of Cancer | 3 | 2020 | 3238 | 0.170 |
Why?
|
Disclosure | 3 | 2015 | 756 | 0.170 |
Why?
|
Intestinal Mucosa | 5 | 2021 | 3048 | 0.160 |
Why?
|
Interleukins | 1 | 2024 | 789 | 0.160 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2019 | 295 | 0.160 |
Why?
|
Health Services Research | 2 | 2017 | 1811 | 0.160 |
Why?
|
Follow-Up Studies | 16 | 2018 | 39228 | 0.160 |
Why?
|
Nitroimidazoles | 2 | 2010 | 118 | 0.150 |
Why?
|
Tuberculosis | 1 | 2011 | 2009 | 0.150 |
Why?
|
Diagnosis, Differential | 6 | 2013 | 12973 | 0.150 |
Why?
|
Vaccination | 1 | 2011 | 3430 | 0.150 |
Why?
|
Risk Assessment | 8 | 2024 | 24275 | 0.150 |
Why?
|
Anticoagulants | 1 | 2014 | 4856 | 0.150 |
Why?
|
Sentinel Surveillance | 1 | 2020 | 292 | 0.150 |
Why?
|
Intra-Abdominal Fat | 1 | 2023 | 624 | 0.150 |
Why?
|
Recurrence | 6 | 2020 | 8492 | 0.150 |
Why?
|
Sexually Transmitted Diseases | 1 | 2024 | 668 | 0.150 |
Why?
|
Aged, 80 and over | 11 | 2022 | 59496 | 0.140 |
Why?
|
Risk Factors | 15 | 2019 | 74850 | 0.140 |
Why?
|
Drug Therapy, Combination | 4 | 2018 | 6306 | 0.140 |
Why?
|
Sensitivity and Specificity | 6 | 2021 | 14643 | 0.140 |
Why?
|
Moxibustion | 1 | 2016 | 5 | 0.140 |
Why?
|
Anti-Bacterial Agents | 3 | 2022 | 7473 | 0.140 |
Why?
|
Multicenter Studies as Topic | 1 | 2022 | 1729 | 0.140 |
Why?
|
Trichuris | 1 | 2016 | 32 | 0.140 |
Why?
|
Cytokine Receptor Common beta Subunit | 1 | 2016 | 22 | 0.130 |
Why?
|
Hypnosis | 1 | 2016 | 83 | 0.130 |
Why?
|
Focus Groups | 4 | 2021 | 1458 | 0.130 |
Why?
|
Enteric Nervous System | 2 | 2017 | 213 | 0.130 |
Why?
|
Academic Medical Centers | 2 | 2017 | 2782 | 0.130 |
Why?
|
Plant Preparations | 1 | 2016 | 93 | 0.130 |
Why?
|
Pregnancy | 7 | 2024 | 30230 | 0.130 |
Why?
|
Chi-Square Distribution | 2 | 2014 | 3430 | 0.130 |
Why?
|
Radiography | 3 | 2017 | 6941 | 0.130 |
Why?
|
Herpes Zoster Vaccine | 1 | 2016 | 49 | 0.130 |
Why?
|
Neurofibromatosis 1 | 1 | 2001 | 561 | 0.130 |
Why?
|
Proctocolectomy, Restorative | 3 | 2016 | 191 | 0.120 |
Why?
|
Relaxation Therapy | 1 | 2016 | 180 | 0.120 |
Why?
|
Live Birth | 2 | 2016 | 516 | 0.120 |
Why?
|
Immunoglobulin Fab Fragments | 3 | 2011 | 443 | 0.120 |
Why?
|
Anastomosis, Surgical | 2 | 2016 | 992 | 0.120 |
Why?
|
Education, Medical, Continuing | 1 | 2020 | 829 | 0.120 |
Why?
|
Aged | 17 | 2022 | 171163 | 0.120 |
Why?
|
Diagnosis-Related Groups | 1 | 2016 | 445 | 0.120 |
Why?
|
Ileostomy | 1 | 2015 | 122 | 0.120 |
Why?
|
Integrins | 1 | 2019 | 838 | 0.120 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 788 | 0.120 |
Why?
|
Jews | 1 | 2016 | 359 | 0.120 |
Why?
|
Government Regulation | 1 | 2019 | 525 | 0.120 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2014 | 85 | 0.120 |
Why?
|
Frameshift Mutation | 1 | 2016 | 392 | 0.110 |
Why?
|
Needs Assessment | 1 | 2020 | 1140 | 0.110 |
Why?
|
Logistic Models | 3 | 2015 | 13273 | 0.110 |
Why?
|
Boston | 3 | 2016 | 9334 | 0.110 |
Why?
|
Infection Control | 1 | 2021 | 984 | 0.110 |
Why?
|
Ileum | 1 | 2016 | 558 | 0.110 |
Why?
|
Follicle Stimulating Hormone | 1 | 2016 | 731 | 0.110 |
Why?
|
Integrin alpha4 | 1 | 2013 | 89 | 0.110 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 26282 | 0.110 |
Why?
|
Patient Compliance | 2 | 2014 | 2693 | 0.110 |
Why?
|
Lymphoma | 2 | 2021 | 1896 | 0.110 |
Why?
|
Public Health Practice | 1 | 2015 | 219 | 0.110 |
Why?
|
Adenosine Triphosphatases | 1 | 2017 | 839 | 0.110 |
Why?
|
ROC Curve | 2 | 2018 | 3612 | 0.110 |
Why?
|
Mind-Body Therapies | 1 | 2016 | 294 | 0.110 |
Why?
|
Immunoglobulin G | 2 | 2016 | 4555 | 0.100 |
Why?
|
Ganciclovir | 1 | 2013 | 256 | 0.100 |
Why?
|
Secondary Prevention | 4 | 2013 | 1470 | 0.100 |
Why?
|
Salicylic Acid | 1 | 2013 | 60 | 0.100 |
Why?
|
Yoga | 1 | 2016 | 277 | 0.100 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2016 | 890 | 0.100 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4851 | 0.100 |
Why?
|
Injections, Subcutaneous | 2 | 2024 | 682 | 0.100 |
Why?
|
Child | 8 | 2023 | 80568 | 0.100 |
Why?
|
Self Report | 5 | 2015 | 3768 | 0.100 |
Why?
|
Leukocytes, Mononuclear | 3 | 2016 | 1852 | 0.100 |
Why?
|
Acupuncture Therapy | 1 | 2016 | 466 | 0.100 |
Why?
|
Pyrroles | 1 | 2018 | 1119 | 0.100 |
Why?
|
Autoantibodies | 1 | 2021 | 2114 | 0.100 |
Why?
|
Histocytochemistry | 1 | 2013 | 695 | 0.100 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2014 | 344 | 0.100 |
Why?
|
Chronic Disease | 3 | 2021 | 9351 | 0.100 |
Why?
|
Lectins | 1 | 2013 | 487 | 0.090 |
Why?
|
Double-Balloon Enteroscopy | 1 | 2011 | 7 | 0.090 |
Why?
|
Multivariate Analysis | 2 | 2015 | 12059 | 0.090 |
Why?
|
Polyradiculopathy | 1 | 2011 | 23 | 0.090 |
Why?
|
Unnecessary Procedures | 1 | 2015 | 412 | 0.090 |
Why?
|
Hematocrit | 1 | 2013 | 622 | 0.090 |
Why?
|
5'-Nucleotidase | 1 | 2012 | 163 | 0.090 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2012 | 340 | 0.090 |
Why?
|
Osteoarthritis, Hip | 1 | 2015 | 408 | 0.090 |
Why?
|
Placebos | 3 | 2024 | 1659 | 0.090 |
Why?
|
Polyethylene Glycols | 3 | 2011 | 1189 | 0.090 |
Why?
|
Meningitis, Viral | 1 | 2011 | 49 | 0.090 |
Why?
|
DNA, Viral | 1 | 2018 | 2196 | 0.090 |
Why?
|
Chickenpox Vaccine | 1 | 2011 | 39 | 0.090 |
Why?
|
Purines | 1 | 2014 | 616 | 0.090 |
Why?
|
Tuberculin Test | 1 | 2011 | 205 | 0.090 |
Why?
|
Abdominal Pain | 1 | 2017 | 1069 | 0.090 |
Why?
|
Models, Organizational | 1 | 2014 | 548 | 0.090 |
Why?
|
Tissue Distribution | 1 | 2014 | 2270 | 0.090 |
Why?
|
Reproducibility of Results | 4 | 2023 | 20133 | 0.090 |
Why?
|
Patient Admission | 1 | 2018 | 1365 | 0.090 |
Why?
|
Acyclovir | 1 | 2011 | 266 | 0.090 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2011 | 71 | 0.090 |
Why?
|
Hematologic Diseases | 1 | 2014 | 500 | 0.090 |
Why?
|
Steroids | 1 | 2015 | 934 | 0.090 |
Why?
|
Inflammation | 5 | 2014 | 10843 | 0.090 |
Why?
|
Self Efficacy | 1 | 2014 | 641 | 0.090 |
Why?
|
Program Development | 1 | 2016 | 1297 | 0.080 |
Why?
|
Mycobacterium | 1 | 2011 | 252 | 0.080 |
Why?
|
Antiviral Agents | 2 | 2013 | 3053 | 0.080 |
Why?
|
Piperidines | 1 | 2018 | 1664 | 0.080 |
Why?
|
Exercise Therapy | 1 | 2016 | 936 | 0.080 |
Why?
|
Length of Stay | 2 | 2015 | 6486 | 0.080 |
Why?
|
Graft vs Host Disease | 1 | 2022 | 3079 | 0.080 |
Why?
|
Case-Control Studies | 6 | 2017 | 22228 | 0.070 |
Why?
|
Infant, Low Birth Weight | 1 | 2013 | 870 | 0.070 |
Why?
|
Enterobacteriaceae Infections | 1 | 2010 | 190 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6503 | 0.070 |
Why?
|
Hypothalamic Hormones | 1 | 2008 | 146 | 0.070 |
Why?
|
Pituitary Hormones | 1 | 2008 | 183 | 0.070 |
Why?
|
Polysaccharides | 1 | 2014 | 1017 | 0.070 |
Why?
|
Mice, Inbred NOD | 2 | 2022 | 1837 | 0.070 |
Why?
|
Plants, Medicinal | 1 | 2007 | 165 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2021 | 12417 | 0.070 |
Why?
|
Acute Disease | 2 | 2009 | 7236 | 0.070 |
Why?
|
Receptors, Corticotropin-Releasing Hormone | 1 | 2007 | 88 | 0.070 |
Why?
|
Heparin | 1 | 2014 | 1632 | 0.070 |
Why?
|
Immune Tolerance | 2 | 2014 | 2324 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2020 | 3111 | 0.070 |
Why?
|
Dietary Supplements | 2 | 2016 | 3427 | 0.070 |
Why?
|
Qualitative Research | 2 | 2015 | 3136 | 0.070 |
Why?
|
Melanins | 1 | 2008 | 291 | 0.070 |
Why?
|
Pyrimidines | 1 | 2018 | 3049 | 0.060 |
Why?
|
Patient-Centered Care | 1 | 2016 | 1447 | 0.060 |
Why?
|
Forecasting | 2 | 2022 | 2936 | 0.060 |
Why?
|
Immunologic Memory | 1 | 2012 | 1374 | 0.060 |
Why?
|
Phytotherapy | 1 | 2007 | 296 | 0.060 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2007 | 362 | 0.060 |
Why?
|
Postoperative Complications | 3 | 2015 | 15802 | 0.060 |
Why?
|
Abdomen | 1 | 2011 | 1135 | 0.060 |
Why?
|
Osteoarthritis, Knee | 1 | 2015 | 1247 | 0.060 |
Why?
|
Intestinal Absorption | 1 | 2006 | 400 | 0.060 |
Why?
|
Antibodies, Viral | 1 | 2016 | 3213 | 0.060 |
Why?
|
Vitamin D Deficiency | 1 | 2014 | 1348 | 0.060 |
Why?
|
Comorbidity | 1 | 2019 | 10575 | 0.060 |
Why?
|
Antibiotic Prophylaxis | 1 | 2010 | 641 | 0.060 |
Why?
|
Clinical Competence | 1 | 2020 | 4855 | 0.060 |
Why?
|
Premedication | 1 | 2005 | 245 | 0.060 |
Why?
|
Biopsy | 2 | 2013 | 6766 | 0.060 |
Why?
|
Lung Diseases | 1 | 2014 | 1939 | 0.060 |
Why?
|
Interleukin-8 | 3 | 2016 | 699 | 0.060 |
Why?
|
Nervous System Diseases | 1 | 2014 | 1657 | 0.050 |
Why?
|
Parkinson Disease | 1 | 2018 | 2885 | 0.050 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2844 | 0.050 |
Why?
|
Placebo Effect | 1 | 2007 | 515 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2014 | 4405 | 0.050 |
Why?
|
Psoriasis | 1 | 2011 | 922 | 0.050 |
Why?
|
Drug Resistance | 1 | 2009 | 1588 | 0.050 |
Why?
|
Registries | 1 | 2019 | 8346 | 0.050 |
Why?
|
Adaptation, Psychological | 1 | 2014 | 2662 | 0.050 |
Why?
|
Phosphoglycerate Kinase | 1 | 2022 | 65 | 0.050 |
Why?
|
Fructose-Bisphosphate Aldolase | 1 | 2022 | 43 | 0.050 |
Why?
|
Metronidazole | 1 | 2004 | 236 | 0.050 |
Why?
|
Data Collection | 1 | 2012 | 3318 | 0.050 |
Why?
|
Genetic Variation | 1 | 2018 | 6612 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 3 | 2017 | 36547 | 0.050 |
Why?
|
Age Factors | 2 | 2016 | 18382 | 0.050 |
Why?
|
Ciprofloxacin | 1 | 2004 | 314 | 0.050 |
Why?
|
Benzene | 1 | 2022 | 106 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12803 | 0.050 |
Why?
|
Heart Diseases | 1 | 2014 | 2818 | 0.050 |
Why?
|
Pilot Projects | 1 | 2014 | 8724 | 0.050 |
Why?
|
Video Recording | 1 | 2006 | 977 | 0.050 |
Why?
|
Asymptomatic Diseases | 1 | 2024 | 586 | 0.050 |
Why?
|
Immunity, Mucosal | 1 | 2004 | 498 | 0.050 |
Why?
|
Formularies as Topic | 1 | 2021 | 93 | 0.050 |
Why?
|
Chemoprevention | 1 | 2003 | 327 | 0.040 |
Why?
|
Budesonide | 1 | 2022 | 162 | 0.040 |
Why?
|
Antibody Formation | 1 | 2005 | 1392 | 0.040 |
Why?
|
Bilirubin | 1 | 2022 | 439 | 0.040 |
Why?
|
United States | 3 | 2019 | 72909 | 0.040 |
Why?
|
Premature Birth | 1 | 2013 | 1830 | 0.040 |
Why?
|
Carcinoma, Papillary | 1 | 2006 | 786 | 0.040 |
Why?
|
Vitamin D | 1 | 2014 | 3272 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11858 | 0.040 |
Why?
|
Pharmaceutical Services | 1 | 2021 | 145 | 0.040 |
Why?
|
Regression Analysis | 1 | 2009 | 6321 | 0.040 |
Why?
|
Social Support | 1 | 2009 | 2190 | 0.040 |
Why?
|
Ultrasonography | 1 | 2013 | 5987 | 0.040 |
Why?
|
Quality-Adjusted Life Years | 2 | 2020 | 1740 | 0.040 |
Why?
|
Area Under Curve | 2 | 2014 | 1637 | 0.040 |
Why?
|
Immunoglobulin E | 1 | 2005 | 1479 | 0.040 |
Why?
|
Interleukin-17 | 2 | 2015 | 921 | 0.040 |
Why?
|
Animals | 8 | 2022 | 168735 | 0.040 |
Why?
|
Biomedical Research | 1 | 2014 | 3458 | 0.040 |
Why?
|
Anaphylaxis | 1 | 2005 | 738 | 0.040 |
Why?
|
Health Personnel | 1 | 2012 | 3385 | 0.040 |
Why?
|
Body Mass Index | 1 | 2016 | 13042 | 0.040 |
Why?
|
Intestines | 3 | 2016 | 1906 | 0.040 |
Why?
|
Feces | 1 | 2024 | 1503 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 18074 | 0.040 |
Why?
|
Patient Selection | 1 | 2009 | 4248 | 0.030 |
Why?
|
Mice | 7 | 2022 | 81782 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2022 | 1181 | 0.030 |
Why?
|
Causality | 1 | 2023 | 1247 | 0.030 |
Why?
|
Reference Standards | 1 | 2020 | 1011 | 0.030 |
Why?
|
Anti-Infective Agents | 1 | 2004 | 985 | 0.030 |
Why?
|
Dextran Sulfate | 1 | 2017 | 255 | 0.030 |
Why?
|
Health Care Surveys | 2 | 2014 | 2426 | 0.030 |
Why?
|
Administration, Rectal | 1 | 2015 | 69 | 0.030 |
Why?
|
Prevalence | 1 | 2013 | 15828 | 0.030 |
Why?
|
Methotrexate | 1 | 2022 | 1719 | 0.030 |
Why?
|
Referral and Consultation | 2 | 2020 | 3615 | 0.030 |
Why?
|
Herpesvirus 4, Human | 1 | 2021 | 1077 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1623 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2007 | 3684 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2018 | 820 | 0.030 |
Why?
|
Antibodies, Fungal | 1 | 2014 | 33 | 0.030 |
Why?
|
Review Literature as Topic | 1 | 2016 | 297 | 0.030 |
Why?
|
Sphingomyelin Phosphodiesterase | 1 | 2014 | 83 | 0.030 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2018 | 878 | 0.030 |
Why?
|
Porins | 1 | 2014 | 78 | 0.030 |
Why?
|
Biomedical Technology | 1 | 2016 | 210 | 0.030 |
Why?
|
Salicylates | 1 | 2014 | 125 | 0.030 |
Why?
|
Sexual Behavior | 1 | 2024 | 2192 | 0.030 |
Why?
|
Cytodiagnosis | 1 | 2017 | 450 | 0.030 |
Why?
|
Motivation | 2 | 2014 | 2018 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3343 | 0.030 |
Why?
|
Infant | 2 | 2018 | 36426 | 0.030 |
Why?
|
Administration, Oral | 3 | 2006 | 4016 | 0.030 |
Why?
|
Life Style | 2 | 2015 | 3928 | 0.030 |
Why?
|
Cost-Benefit Analysis | 2 | 2020 | 5531 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2014 | 5880 | 0.030 |
Why?
|
Child, Preschool | 2 | 2018 | 42510 | 0.030 |
Why?
|
Cytoskeleton | 1 | 2018 | 1178 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2013 | 26380 | 0.030 |
Why?
|
Colorimetry | 1 | 2013 | 147 | 0.020 |
Why?
|
Thyroid Neoplasms | 1 | 2006 | 2354 | 0.020 |
Why?
|
Probability | 2 | 2009 | 2474 | 0.020 |
Why?
|
Anemia, Sickle Cell | 1 | 2001 | 1063 | 0.020 |
Why?
|
Quality of Life | 2 | 2014 | 13463 | 0.020 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2014 | 297 | 0.020 |
Why?
|
Serologic Tests | 1 | 2014 | 382 | 0.020 |
Why?
|
Pregnancy Rate | 1 | 2014 | 654 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2007 | 8037 | 0.020 |
Why?
|
Specialization | 1 | 2016 | 779 | 0.020 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2014 | 403 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2012 | 472 | 0.020 |
Why?
|
Gene Frequency | 1 | 2018 | 3623 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2016 | 931 | 0.020 |
Why?
|
Bone and Bones | 1 | 2021 | 2555 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2014 | 871 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 2016 | 998 | 0.020 |
Why?
|
Autophagy | 1 | 2018 | 1350 | 0.020 |
Why?
|
Decision Trees | 1 | 2011 | 509 | 0.020 |
Why?
|
Incidence | 2 | 2009 | 21513 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2021 | 3447 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1748 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2013 | 991 | 0.020 |
Why?
|
Safety | 1 | 2013 | 1157 | 0.020 |
Why?
|
Trinitrobenzenesulfonic Acid | 1 | 2008 | 65 | 0.020 |
Why?
|
Genetic Loci | 1 | 2018 | 2630 | 0.020 |
Why?
|
Drug Eruptions | 1 | 2011 | 334 | 0.020 |
Why?
|
Reference Values | 2 | 2006 | 4909 | 0.020 |
Why?
|
Antibodies, Bacterial | 1 | 2014 | 1473 | 0.020 |
Why?
|
Phenotype | 2 | 2018 | 16714 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2012 | 1865 | 0.020 |
Why?
|
Urocortins | 1 | 2007 | 20 | 0.020 |
Why?
|
Disease Progression | 1 | 2024 | 13614 | 0.020 |
Why?
|
Monocytes | 1 | 2016 | 2591 | 0.020 |
Why?
|
Alleles | 1 | 2018 | 6891 | 0.020 |
Why?
|
Anxiety | 1 | 2021 | 4669 | 0.020 |
Why?
|
Postoperative Period | 1 | 2011 | 1818 | 0.020 |
Why?
|
Cytokines | 1 | 2021 | 7417 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2013 | 1194 | 0.020 |
Why?
|
Computer Simulation | 1 | 2020 | 6251 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2011 | 1238 | 0.020 |
Why?
|
Health Services Accessibility | 2 | 2014 | 5509 | 0.020 |
Why?
|
Enema | 1 | 2006 | 140 | 0.020 |
Why?
|
Enterotoxins | 1 | 2007 | 366 | 0.020 |
Why?
|
Attitude to Health | 1 | 2014 | 2020 | 0.020 |
Why?
|
Genome, Human | 1 | 2018 | 4443 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3796 | 0.010 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2012 | 1374 | 0.010 |
Why?
|
Sex Distribution | 1 | 2009 | 2269 | 0.010 |
Why?
|
Administration, Topical | 1 | 2006 | 702 | 0.010 |
Why?
|
Population Surveillance | 1 | 2014 | 2596 | 0.010 |
Why?
|
Communicable Diseases | 1 | 2012 | 873 | 0.010 |
Why?
|
Age Distribution | 1 | 2009 | 2864 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2014 | 2674 | 0.010 |
Why?
|
Macrophages | 1 | 2018 | 5772 | 0.010 |
Why?
|
Neuropeptides | 1 | 2008 | 952 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2008 | 2915 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 8060 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2007 | 1239 | 0.010 |
Why?
|
Signal Transduction | 2 | 2016 | 23597 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 14450 | 0.010 |
Why?
|
Mice, SCID | 1 | 2007 | 2626 | 0.010 |
Why?
|
Sex Factors | 1 | 2015 | 10611 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8721 | 0.010 |
Why?
|
Bacterial Toxins | 1 | 2007 | 924 | 0.010 |
Why?
|
Europe | 1 | 2008 | 3430 | 0.010 |
Why?
|
Quality Improvement | 1 | 2016 | 3847 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2016 | 18962 | 0.010 |
Why?
|
Primary Health Care | 1 | 2016 | 4736 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22327 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2007 | 2390 | 0.010 |
Why?
|
NF-kappa B | 1 | 2007 | 2492 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10426 | 0.010 |
Why?
|
Health Care Costs | 1 | 2011 | 3241 | 0.010 |
Why?
|
Pedigree | 1 | 2006 | 4535 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2013 | 9525 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2008 | 9541 | 0.010 |
Why?
|
Cell Line | 1 | 2007 | 15540 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2007 | 12768 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 11895 | 0.000 |
Why?
|